the present invention relates to the use of creatine compounds for treating or preventing a metabolic disorder related to body weight control such as obesity , and it &# 39 ; s associated diseases in a patient experiencing said disorder . the creatine compounds which can be used in the present method include analogues of creatine which can act as substrates or substrate analogues for the enzyme creatine kinase ; compounds which can act as inhibitors of creatine kinase ; compounds which can modulate the creatine transporter n - phosphocreatine analogues bearing transferable or non - transferable moieties which mimic the n - phosphoryl group . compounds which modify the association of creatine kinase with other cellular components .